More patients than ever are struggling to afford their medications for a variety of reasons, including high out-of-pocket costs or being underinsured. These difficulties increase the risk that people won’t adhere to their prescribed therapy, either by skipping doses to make their prescription last longer, or not starting therapy at all.
of patients[0]CoverMyMeds Patient and Provider Surveys, 2020
When patients can’t afford their prescriptions, 52% seek affordability options through their provider — and 29% go without their medications.
patients[0]CoverMyMeds Patient Survey, 2020
of patients[0]CoverMyMeds Patient Survey, 2022
We help to minimize barriers throughout the prescription journey. Whether it's giving providers visibility into a patient's plan benefit or leveraging our leading pharmacy network to surface cash and pharma-sponsored savings, we help ensure patients access affordable medications when and where it matters. We align with your business goals to help you enable patients to afford their medications.
More fulfillment[0]CoverMyMeds case study, 2019
in brand savings using CoverMyMeds’ Copay Maximizer mitigation functionality[0]CoverMyMeds data on file; January 2023 – December 2023
Commercial claims processed on the CoverMyMeds switch network, spanning over 50,000 pharmacies[0]CoverMyMeds Claims Data on File. Date range: January–December 2023
in patient savings on specialty and brand medications[0]CoverMyMeds data on file, 2024
Keeping patients at the center of affordability program design is crucial to overall success. Learn more about how CoverMyMeds is paving the way forward for medication affordability — impacting access and adherence to prescribed therapies.
Affordability barriers present an opportunity for pharma companies to explore new solutions for more patients to access their prescribed therapies. The right data and insights can help inform these efforts to create real-world solutions to affordability problems. In this report, we discuss common factors impacting patients' ability to afford their medications and how pharma companies can respond.
It’s scary for patients to be stuck with a huge, unexpected cost, and it impacts their health, no matter what condition they have...Treatment these days is prevention.